Skip to main navigation
Skip to search
Skip to main content
Experts@Minnesota Home
Home
Profiles
Research units
University Assets
Projects and Grants
Research output
Datasets
Press/Media
Activities
Fellowships, Honors, and Prizes
Impacts
Search by expertise, name or affiliation
CRISPR-Cas9 cytidine and adenosine base editing of splice-sites mediates highly-efficient disruption of proteins in primary and immortalized cells
Mitchell G. Kluesner
, Walker S. Lahr
,
Cara lin Lonetree
, Branden A. Smeester
, Xiaohong Qiu
,
Nicholas J. Slipek
, Patricia N. Claudio Vázquez
, Samuel P. Pitzen
, Emily J. Pomeroy
, Madison J. Vignes
, Samantha C. Lee
, Samuel P. Bingea
, Aneesha A. Andrew
,
Beau R. Webber
,
Branden S. Moriarity
Pediatric Hematology/Oncology
Genetics Mechanisms of Cancer
Administration (CBS)
Microbiology
Laboratory Medicine and Pathology
Pediatric Blood & Marrow Transplant & Cellular Therapy
Center for Genome Engineering
Transplant and Cellular Therapy
Research output
:
Contribution to journal
›
Article
›
peer-review
82
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'CRISPR-Cas9 cytidine and adenosine base editing of splice-sites mediates highly-efficient disruption of proteins in primary and immortalized cells'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Adenosine
100%
Primary Cells
100%
Cas9 Protein
100%
Base Editing
100%
Cytidine
100%
Splice Site
100%
Single Guide RNA (sgRNA)
100%
High Efficiency
100%
Immortalized Cell
100%
T Cells
50%
Design Tools
50%
Targeted Gene
50%
MHC Class I
50%
Modular Design
50%
Gene Disruption
50%
Premature Stop Codon
50%
TCR-CD3
50%
Immune Synapse
50%
Ensembl
50%
Splice Acceptor
50%
Annotated Genomes
50%
Depth Comparison
50%
ABE8e
50%
Splicer
50%
Modular Tools
50%
Double-strand Breaks
50%
Base Editor
50%
Biochemistry, Genetics and Molecular Biology
CRISPR/Cas9
100%
Adenosine
100%
Cytidine
100%
MHC Class I
50%
T Cell Receptor
50%
Stop Codon
50%
Gene Targeting
50%
Synapse
50%
Gene Disruption
50%
T Cell
50%
Immunology and Microbiology
CRISPR/Cas9
100%
T Cell Receptor
50%
Synapse
50%
MHC Class I
50%
Gene Disruption
50%
T Cell
50%
Gene Targeting
50%
Stop Codon
50%
CD3 Antigen
50%